Inhibition of COX in ocular tissues: an in vitro model to identify selective COX-2 inhibitors

J Ocul Pharmacol Ther. 2001 Feb;17(1):67-74. doi: 10.1089/108076801750125711.

Abstract

The aim of this work was to study the regulation of LPS-stimulated PGE 2 synthesis by traditional NSAIDs (piroxicam and diclofenac) and a selective COX-2 inhibitor (NS-398), in cultured bovine corneal endothelial cells and retinal pigmentary epithelial cells. The IC50 values of piroxicam and diclofenac were compared with IC50 values of NS-398, diclofenac, in both types of cells, showed higher potency than piroxicam. Diclofenac seemed to be a COX-2 inhibitor because its IC50 values were similar to the IC50 values of NS-398. We suggest that this in vitro cell assay system could be useful for identifying compounds that selectively inhibit COX-2 in ocular tissues.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Cattle
  • Cells, Cultured
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / metabolism*
  • Diclofenac / pharmacology
  • Dinoprostone / biosynthesis
  • Endothelium, Corneal / drug effects
  • Endothelium, Corneal / enzymology*
  • Isoenzymes / antagonists & inhibitors*
  • Lipopolysaccharides / pharmacology
  • Nitrobenzenes / pharmacology
  • Pigment Epithelium of Eye / drug effects
  • Pigment Epithelium of Eye / enzymology*
  • Piroxicam / pharmacology
  • Prostaglandin-Endoperoxide Synthases
  • Salmonella typhimurium
  • Sulfonamides / pharmacology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lipopolysaccharides
  • Nitrobenzenes
  • Sulfonamides
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Piroxicam
  • Diclofenac
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone